Nichelle Stigger is one of several advocates participating in Johnson & Johnson Innovative Medicine's 'BeLUNG Here' initiative (Johnson & Johnson)
February 21, 2024 02:28 PM ESTUpdated 05:50 PM
Pharma
Marketing

J&J so­cial me­dia pro­gram aims to add more di­verse voic­es in lung can­cer ad­vo­ca­cy

Beth Snyder Bulik

Senior Editor

J&J is invit­ing un­der­rep­re­sent­ed peo­ple in the lung can­cer com­mu­ni­ty to be­come dig­i­tal ad­vo­cates through its “BeLUNG Here” ini­tia­tive.

Lung can­cer pa­tients and care­givers can …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times